LM1104

17:0-14:1 PE

Avanti Research^™ - A Croda Brand

• Sinónimos: 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine
• Fórmula empírica (notación de Hill): C₃₆H₇₀NO₈P
• Número de CAS: 958763-89-8
• Peso molecular: 675.92
• UNSPSC Code: 12352211
• NACRES: NA.25

Propiedades

• form: methanol solution
• packaging: pkg of 1 × 1 mL (LM1104-1EA)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand
• concentration: ~10 μg/mL (Refer to C of A for lot specific concentration.)
• application(s): lipidomics; metabolomics
• shipped in: dry ice
• storage temp.: −20°C
• SMILES string: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCC)=O)COC(CCCCCCCCCCCCCCCC)=O
• InChI key: QWRIURIVRIHUFS-PEDHGXIFSA-N

Descripción

General description

Phosphoethanolamine (PE) acts as a parent compound for phosphatidylcholine and phosphatidylethanolamine synthesis.

Application

17:0-14:1 PE or 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine has been used as an internal standard:

• for lipid quantification using liquid chromatography-mass spectrometry (LC-MS)
• for the detection of lipids by tandem mass spectrometry (MS/MS) (related to lipidome analyses)
• in lipid extraction using MTBE protocol

Biochem/physiol Actions

Phosphoethanolamine (PE) is known to show extensive antitumor action and prevents tumor proliferation, in vivo. Synthetic PE inhibits lung metastasis.

Packaging

2 mL Amber Glass Sealed Ampule (LM1104-1EA)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• pictograms: GHS02,GHS06,GHS08
• signalword: Danger
• hcodes: H225,H301 + H311 + H331,H370
• pcodes: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• target_organs: Eyes
• Storage Class: 3 - Flammable liquids
• wgk_germany: WGK 2
• flash_point_f: 49.5 °F - closed cup
• flash_point_c: 9.7 °C - closed cup